Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Enveric Biosciences Inc (NQ: ENVB ) 0.8300 +0.0020 (+0.24%) Streaming Delayed Price Updated: 4:00 PM EDT, May 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 66,873 Open 0.8100 Bid (Size) 0.8300 (1) Ask (Size) 0.8550 (10) Prev. Close 0.8280 Today's Range 0.8001 - 0.8440 52wk Range 0.6490 - 6.980 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News ENVB Stock Earnings: Enveric Biosciences Beats EPS for Q1 2024 May 20, 2024 ENVB stock results show that Enveric Biosciences beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace 'Psychedelics-Inspired' Meds For Depression, Anxiety, Addiction Producer Trims Q1 Net Loss YoY, Increases Cash On Hand May 16, 2024 Enveric Biosciences reported on Wednesday financial results for the first quarter of 2024 ended March 31, 2024."We believe the first quarter of 2024 was a highly productive period for Enveric as the... Via Benzinga Performance YTD -34.13% -34.13% 1 Month -3.60% -3.60% 3 Month -3.15% -3.15% 6 Month -40.73% -40.73% 1 Year -73.65% -73.65% More News Read More Enveric Biosciences Reports First Quarter 2024 Financial and Corporate Results May 15, 2024 From Enveric Biosciences Via Business Wire Microdosing For Depression: Psychedelics Biotech Signs $66.5M Non-Binding Deal To Out-License Novel Psilocin Prodrug Candidate May 14, 2024 Via Benzinga Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders May 14, 2024 From Enveric Biosciences Via Business Wire 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 08, 2024 Via Benzinga Cannabinoids With Chemotherapy For Breast Cancer: Psychedelics Biotech Inks $61M License Deal For Patented Methods May 08, 2024 Via Benzinga Topics Cannabis Exposures Cannabis Enveric Biosciences Announces Signing of Non-Binding Term Sheet with Undisclosed Licensee for Exclusive License to Patented Methods of Treating Breast and Other Cancers Using Cannabinoids May 08, 2024 From Enveric Biosciences Via Business Wire Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More April 17, 2024 Via Benzinga Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session April 03, 2024 Via Benzinga Exposures Glyphosate 12 Health Care Stocks Moving In Wednesday's Pre-Market Session April 03, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session April 02, 2024 Via Benzinga ENVB Stock Earnings: Enveric Biosciences Beats EPS for Q4 2023 April 01, 2024 Via InvestorPlace Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence March 29, 2024 Via Benzinga Enveric Biosciences Optimistic On Q4 And Full-Year Results: 'Psychedelic-Inspired' Meds For Future Growth March 27, 2024 Via Benzinga Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023 March 26, 2024 From Enveric Biosciences Via Business Wire Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More March 20, 2024 Via Benzinga Topics Economy Exposures Interest Rates 12 Health Care Stocks Moving In Tuesday's After-Market Session March 19, 2024 Via Benzinga Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session March 19, 2024 Via Benzinga Nasdaq Down 100 Points; US Housing Starts Surge In February March 19, 2024 Via Benzinga Topics Stocks Exposures US Equities Why Is Anxiety/Addiction-Focused Enveric Biosciences Stock Trading Higher Tuesday? March 19, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session March 19, 2024 Via Benzinga Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease March 19, 2024 From Enveric Biosciences Via Business Wire Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review March 16, 2024 Via Benzinga Enveric Biosciences Announces New Patent Issuances Protecting Multiple Assets Covered by Non-Binding Term Sheets March 12, 2024 From Enveric Biosciences Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
